Studies have demonstrated that myeloma cells down-regulate OPG production in stromal cells and osteoblasts in a contact dependent manner [8], [9], [16] and that serum concentrations of OPG are decreased in patients with myeloma [17], . The gene discussed is TNFRSF11B; the disease is plasma cell myeloma.